RIL
INDV icon

Rothschild Investment LLC’s Indivior Pharmaceuticals INDV Stock Holding History

Rothschild Investment LLC’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.92K Buy
193
+10
+5% +$363 ﹤0.01% 2022
2026
Q1 		$5.58K Sell
183
-23
-11% -$760 ﹤0.01% 1998
2025
Q4 		$7.39K Buy
206
+66
+47% +$2.02K ﹤0.01% 1701
2025
Q3 		$3.38K Sell
140
-35
-20% -$732 ﹤0.01% 1915
2025
Q2 		$2.58K Buy
+175
New +$2.04K ﹤0.01% 1886

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's INDV Position: Q2 2026 in Review

Rothschild Investment LLC increased its Indivior Pharmaceuticals (INDV) stake by 5.5% in Q2 2026, buying an estimated $363 and bringing the position to 193 shares worth $7.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Rothschild Investment LLC first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 314 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Rothschild Investment LLC held 193 shares of Indivior Pharmaceuticals worth $7.92K as of Q2 2026.
  • Rothschild Investment LLC bought 10 Indivior Pharmaceuticals shares in Q2 2026, an estimated $363.
  • Indivior Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2022 holding.
  • Rothschild Investment LLC first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 314 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.